Krishnan Suma sold KRYS
July 15, 2025 · Form 4 insider transaction
Krishnan Suma sold 800 shares of Krystal Biotech, Inc. at $151.79 per share, a transaction worth $121.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
800
Price
$151.79
Total value
$121.4K
InsiderKrishnan Suma
Role—
CompanyKrystal Biotech, Inc. (KRYS)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJuly 15, 2025
Filing dateJuly 16, 2025
Shares owned after1,440,240
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The Rule 10b5-1 trading plan started on September 12, 2024, and contemplated quarterly sales of 25,000 shares of Common Stock. The Rule 10b5-1 trading plan has reached the maximum number of shares to be sold under such plan and has terminated.; The transaction was executed in one trade.